Search

everythinglearnresearchcommunity

for

Search:↓

Human hair follicles have a unique metabolism that changes between growth stages and may contribute to baldness.

Greek women with classic PCOS are more likely to have metabolic syndrome and insulin resistance than those with newer PCOS types.

The research found that PCOS has common genetic factors regardless of how it is diagnosed and is linked to metabolic and reproductive issues.

Testosterone therapy in transgender men has both desired effects like increased muscle mass and potential health risks such as higher cardiovascular risk.

Too much male hormone is the main cause of Polycystic Ovary Syndrome.

Women with PCOS have higher androgen levels that decrease with age but are still higher than in women without PCOS.

Adults with polycystic ovary syndrome are much more likely to have obstructive sleep apnea.

Obese women with PCOS show a male-like pattern in certain fat tissue gene expressions.

Defective mitochondrial DNA replication causes aging symptoms and increased oxidative damage in mice.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.

Different lab conditions and light treatment methods change how human skin cells respond to light therapy.

The review found no clear link between vitamin D receptor gene variations and polycystic ovary syndrome.

Metformin should be used for PCOS mainly in those with glucose intolerance, and has limited benefits for infertility or hirsutism.

Men with benign prostatic hyperplasia are more likely to have metabolic syndrome than those without it.

Hormonal therapy is a good option for women with severe acne, especially when there's a chance of hormone imbalance.

Small changes in hormones can significantly impact health, showing the importance of sensitive testing for chemicals that disrupt hormones.

The study found that women with hyperandrogenic PCOS have higher levels of AKT1 and AKT2 proteins in their cells, which may lead to cell dysfunction.

Balding people may have higher heart disease risk.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Chromium supplements don't improve insulin, hormone levels, or cholesterol in women with PCOS but raise testosterone levels.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Testosterone therapy helped 63% of androgen-deficient women grow scalp hair, but more research is needed.

Blood hormone levels don't accurately show brain hormone levels in males.

The document says menstruation is important for women's health, discusses menstrual disorders, and suggests personalized treatment options.

FAI values above 6.4 may suggest high androgen levels and increased metabolic risks in Chinese women of reproductive age.

Larger ovarian size is linked to higher insulin resistance in women with PCOS.

The document concludes that PCOS has a strong genetic component, but more research is needed to fully understand the specific genes involved.

Testosterone replacement therapy should be used for men with low testosterone levels and symptoms of hypogonadism, after careful diagnosis and considering individual needs.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.